Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.17%161.87M | 15.94%156.43M | -5.66%132.56M | 13.81%569.2M | 13.67%149.46M | 8.08%144.31M | 11.37%134.93M | 23.27%140.52M | -3.29%500.15M | -2.80%131.49M |
| Cost of revenue | 14.86%308.14M | 0.25%268.27M | ||||||||
| Gross profit | 12.59%261.06M | 13.67%149.46M | -7.10%231.88M | 131.49M | ||||||
| Operating expense | 1.19%96.56M | 23.01%108.63M | -7.07%83.68M | -3.75%61.84M | 7.95%96.2M | 8.64%95.43M | 15.30%88.31M | 14.73%90.05M | -12.24%64.25M | 151.27%89.11M |
| Selling and administrative expenses | ---- | ---- | ---- | 8.86%66.99M | ---- | ---- | ---- | ---- | -11.02%61.54M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 8.86%66.99M | ---- | ---- | ---- | ---- | -11.02%61.54M | ---- |
| Depreciation and amortization | 7.21%5.49M | 3.93%5.42M | -1.71%5.23M | 2.18%20.68M | -4.12%5.03M | 0.10%5.12M | 3.25%5.21M | 10.09%5.32M | --20.24M | --5.24M |
| -Depreciation | 7.21%5.49M | 3.93%5.42M | -1.71%5.23M | 2.18%20.68M | -4.12%5.03M | 0.10%5.12M | 3.25%5.21M | 10.09%5.32M | --20.24M | --5.24M |
| Other operating expenses | 1.85%95.51M | 23.24%106.79M | -7.47%83.98M | 13.78%13.66M | 14.19%96.93M | 10.42%93.77M | 14.58%86.65M | 19.19%90.76M | -1.58%12M | 136.91%84.89M |
| Total other operating income | 28.03%4.43M | 0.59%3.57M | -8.30%5.53M | 102.48%18.81M | 466.76%5.76M | 57.82%3.46M | -12.94%3.55M | 142.04%6.03M | 14.04%9.29M | 1,420.13%1.02M |
| Operating profit | 33.62%65.31M | 2.55%47.8M | -3.15%48.88M | 18.85%199.22M | 25.69%53.26M | 6.99%48.88M | 4.62%46.61M | 42.17%50.47M | -4.96%167.62M | 2.11%42.38M |
| Net non-operating interest income (expenses) | -4.71%-200K | 15.38%-176K | 16.89%-182K | 24.34%-794.59K | 16.90%-177K | 12.39%-191K | 15.45%-208K | 41.29%-219K | -26.40%-1.05M | 6.93%-213K |
| Non-operating interest expense | 4.71%200K | -15.38%176K | -16.89%182K | -24.34%794.59K | -16.90%177K | -12.39%191K | -15.45%208K | -41.29%219K | 26.40%1.05M | -6.93%213K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 164.85%492.66K | ||||||||
| Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -164.85%-492.66K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 33.73%65.11M | 2.63%47.62M | -3.09%48.7M | 18.77%198.43M | 25.91%53.09M | 7.08%48.69M | 4.73%46.4M | 43.06%50.25M | -4.42%167.07M | 4.07%42.16M |
| Income tax | 52.66%14.97M | 11.70%11.09M | -13.35%14.58M | 10.82%47.35M | 21.11%10.79M | -36.71%9.81M | 6.40%9.92M | 87.05%16.83M | 7.83%42.73M | 23.37%8.91M |
| Net income | 28.96%50.14M | 0.16%36.54M | 2.07%34.12M | 21.51%151.08M | 27.19%42.3M | 29.72%38.88M | 4.28%36.48M | 27.91%33.43M | -8.01%124.34M | -0.11%33.25M |
| Net income continuous operations | 28.96%50.14M | 0.16%36.54M | 2.07%34.12M | 21.51%151.08M | 27.19%42.3M | 29.72%38.88M | 4.28%36.48M | 27.91%33.43M | -8.01%124.34M | -0.11%33.25M |
| Noncontrolling interests | 21.09%4.31M | -3.08%3.05M | -9.55%3.05M | 15.23%14.28M | 18.42%4.2M | 10.26%3.56M | 2.54%3.15M | 32.38%3.37M | 4.32%12.39M | 2.85%3.55M |
| Net income attributable to the company | 29.75%45.83M | 0.46%33.49M | 3.37%31.07M | 22.20%136.81M | 28.24%38.1M | 32.07%35.32M | 4.45%33.33M | 27.43%30.05M | -9.20%111.95M | -0.46%29.71M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 29.75%45.83M | 0.46%33.49M | 3.37%31.07M | 22.20%136.81M | 28.24%38.1M | 32.07%35.32M | 4.45%33.33M | 27.43%30.05M | -9.20%111.95M | -0.46%29.71M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 29.02%0.0289 | -0.47%0.0211 | 2.62%0.0196 | 21.77%0.0867 | 27.51%0.0241 | 31.76%0.0224 | 4.43%0.0212 | 27.33%0.0191 | -9.18%0.0712 | 0.00%0.0189 |
| Diluted earnings per share | 26.79%0.0284 | 32.70%0.0211 | 2.09%0.0195 | 20.79%0.086 | -3.70%0.0182 | 31.76%0.0224 | -21.67%0.0159 | 27.33%0.0191 | -9.18%0.0712 | 0.00%0.0189 |
| Dividend per share | 17.65%0.02 | 0 | 0.02 | 50.00%0.039 | 0 | 0.017 | -15.38%0.022 | 0 | -36.59%0.026 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.